Author:
Ansari M,Huezo-Diaz P,Rezgui M A,Marktel S,Duval M,Bittencourt H,Cappelli B,Krajinovic M
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference42 articles.
1. Modell B, Darlison M . Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480–487.
2. Lucarelli G, Angelucci E Allogeneic hematopoietic stem cell transplantation for thalassemia. In: Atkinson K, Champlin R, Ritz J, Fibbe WE, Ljungman P, Brenner MK (eds). Clinical bone marrow and blood stem cell transplantation. Cambridge University Press: Cambridge, 2004, pp 929–946.
3. Lucarelli G, Isgro A, Sodani P, Gaziev J . Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med 2012; 2: a011825.
4. Bernardo ME, Piras E, Vacca A, Giorgiani G, Zecca M, Bertaina A et al. Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan. Blood 2012; 120: 473–476.
5. Mathews V, George B, Viswabandya A, Abraham A, Ahmed R, Ganapule A et al. Improved clinical outcomes of high risk beta thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning regimen and peripheral blood stem cell grafts. PLoS ONE 2013; 8: e61637.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献